Seminars and Symposia

• November 13 - Vladimir Badovinac, Ph.D., seminar: "Sepsis induced alterations in T cell mediated immunity"
• October 9 - Edmund Au, Ph.D., seminar: "Elucidating Principles of Cortical Interneuron Synaptic Organization in Health and Disease"
• October 8 - Howard J. Worman, M.D., seminar: " Nuclear Envelope to Human Disease. What a Long, Strange Trip It’s Been"
• October 1 - Dongfang Liu, Ph.D., seminar: "CD147-CAR-NK for Solid Tumor Treatment and Immunological Synapse Application"
• September 24 - James L.M. Ferrara, MD, DSc, seminar: "Graft versus Host Disease: A tale of Life and Death"
• September 19 - CDI Research Day - Agenda and Abstract Book (PDF)
• September 10 - Dongfang Liu, Ph.D., seminar: “Title TBD”
• June 11 - Yiping W. Han, Ph.D., seminar: "Mechanistic insights of Fusobacterium nucleatum in GI cancers"
• May 30 - Applied Immunological Research Symposium
  For more information, click here.
• May 23 - Da Yang, M.D., Ph.D., seminar: "Bridging Genomic Landscapes to Translational Pharmacogenomics in Disease"
• May 16 - CDI Postdoctoral Seminar Raju Shivarathri, Ph.D., "Complement C3 promotes sterilizing pulmonary antifungal immunity" Alireza Labani Motlagh, Ph.D., "Mutant p53 renders resistance to checkpoint inhibitor-based tumor immunotherapy through inducing autophagy"
• Workshop series on writing a research article | 1 to 2:30 pm (Building 111, Room# 105)
  • April 5 - Results
  • April 12 - Introduction
  • April 19 - Discussion
  • April 26 - Abstract
• April 23 - Marta Catalfamo, Ph.D., seminar: “The interplay between T cell immune activation and endothelial inflammation in HIV infection: mechanisms and implications”
• April 9 - Joseph Sun, Ph.D., seminar: “Epigenetic control of NK cells”
• April 2 - Eric Rubin, M.D., Ph.D., seminar: “Safe but not too safe – human challenge for tuberculosis”
• March 13 - Xiaosong Wang, M.D., Ph.D., seminar: "Pathological and Therapeutic Roles of Recurrent Adjacent Gene Rearrangements in More Aggressive and Therapy-resistant Breast Cancers"
• March 6-8 - Center for PFAS and Cancer (CPAC) Joint Virtual Symposium (Agenda-PDF)
• February 27 - Jansy Sarathy, Ph.D. - CDI Faculty member seminar: "Lesion-centric PK/PD considerations for TB drug discovery and regimen design"
• February 20 - Rena Feinman, Ph.D. - CDI Faculty member seminar: "The microbiome, may the flora be with you!"
• February 6 - Claire Carter, Ph.D. - CDI Faculty member seminar: "Lipids, drugs and the tumor microenvironment: Spatial analysis identifies druggable pathways and informs on therapeutic efficacy"
• February 2 - Jansy Sarathy, Ph.D. - CDI Faculty member seminar: "Lesion-centric PK/PD considerations for TB drug discovery and regimen design"
• January 23 - Gary Kupfer, M.D., seminar: Genetic Basis of Cancer Predisposition: "Basic and Translational Studies"

• December 19 - Ilona Fridman, Ph.D., seminar: "Leveraging Digital Technologies to Enhance Medical Decision-Making for Patients with Cancer"
• December 12 - Xiaoping Zhong, M.D., Ph.D., seminar: "Signal Control in T Cells and Autoimmunity"
• December 7
  • Hariprasad Thangavel, Ph.D., Postdoc seminar: "Adipomes: Key Orchestrators of the Breast Tumor Microenvironment"
  • Yuanyuan Tian, Ph.D., Postdoc seminar: "PDL1 and IFNa: prediction and prevention for GVHD"
• December 5 - Olivier Loudig, Ph.D., CDI Faculty member seminar: "Exhaled extracellular vesicles: How to capture meaningful data out of thin air"
• November 14 - Christian Hinrichs, M.D., seminar: “Cell therapy for HPV-associated cancers and other solid tumors”
• November 7 - Joyce Slingerland, M.D., Ph.D., seminar: "New insights into the pro-oncogenic effects of postmenopausal estrogen, estrone (E1) on breast cancer and the TME"
• October 24 - Christopher Sassetti, Ph.D., seminar: "Mechanisms of genomic plasticity that determine tuberculosis pathogenesis and drug responses"
• October 10 – Ichiro Taniuchi, M.D, Ph.D., seminar: "Roles of Runx transcription factors during immune system development"
• September 26 – Partha S. Biswas, Ph.D., seminar: "Comorbidities: new challenges in the treatment of infectious diseases"
• September 19 – Ji–Yeon Shin, Ph.D., seminar: "The role of nuclear envelope proteins in hepatic lipid metabolism and neoplasia"
• July 18 – Markus Lang, seminar: "AAPs as synthetic RNAP–Inhibitors with anti–mycobacterial activity”
• June 26 – Rachel Rosenstein, M.D., Ph.D., seminar: "Cutaneous complications of transplantation"
• June 20 – Byungwoo Ryu, PhD., seminar: "A novel role of CoREST–complex in RNA splicing: a potential target for cancer therapy"
• June 12 – Sarah Shizuko Morimoto, Psy.D., seminar: "A model for digital intervention research in psychiatry." Roger Altizer, Ph.D., seminar: "Playful Innovation in Digital Health"
• June 8 – Dr. Emre Deniz, Postdoc seminar: "Ezrin Asserts its Roles on Osteosarcoma Metastasis Through Interacting with RNAs"
  Dr. Chandra Char, Postdoc seminar: "Hearing Loss & Cancer: Assessing the moderation of race using the NIH All of Us Data set"
• May 25 – Dr. Hariprasad Thangavel, Postdoc seminar: " Adipocyte–tumor cell crosstalk in breast cancer pathogenesis"
  Dr. Jia Liu, Postdoc seminar: "CTCF mediates effector CD8+ T cell differentiation through genomic reorganization"
• May 23 – Dr. Piero D. Dalerba, seminar: “Modeling cancer as a stem cell disease: the “cancer stem cell” theory as a heuristic framework for translational discoveries in medical oncology”
• May 16 – Dr. K. Sandeep Prabhu, seminar: “Bioactive Lipid Mediators in Leukemia Therapy”
• April 26 – Multiple Myeloma and Lymphoma Research Symposium - See event details here.
• March 28 – Dr. Marco Davila, seminar: “Mechanisms of CD19–targeted CAR T cell resistance”
• February 28 – Dr. Richard Pomerantz, seminar: “Development of Next–Generation Precision Medicines for Cancer”
• February 14 – Dr. Abraham Aragones, seminar: “HPV–Associated Cancer Disparities: Lessons from a Community Based Intervention in Four Large and Diverse Cities”
• February 7 – Dr. Hongjun Wang, seminar: “Noble metallic nanostructures for cancer theranostics”
• January 12 – Dr. Gary Kwok, seminar: “Leveraging Meditation Mobile Applications in Survivorship Care among Adolescent and Young Adult Survivors of Childhood Cancer”
• January 10 – Dr. David Wiest, seminar: “Gamma–delta T cells – Ignore them at your own peril”

• December 15, 2022 – Dr. Todd Young, Postdoc seminar: “Expression of amino acid transporters and metabolic enzymes in invasive lobular breast cancer”
• December 1, 2022 – Dr. Yasmine Hassoun, Postdoc seminar: “Mutations in a fatty acid elongase evolve during antifungal drug treatment in Candida glabrata colonizing the gut and contribute to drug tolerance in vivo”
• November 15, 2022 – Dr. Susan M. Rosenberg, Distinguished Speaker seminar: “Drugging evolution of antibiotic resistance”
• November 8, 2022 – Dr. Hai–Hui “Howard” Xue, CDI Faculty Member seminar: “Everything, everywhere, all at once in CD8 T cell immunity”
• October 31, 2022 – Dr. Hui Hu, Distinguished Speaker seminar: “The confusion between Tfh cells and CXCR5+CD4+ T cells: Tfh cell differentiation, where to start?”
• October 25, 2022 – Dr. Thomas Dick, CDI Faculty Member seminar: “New antibiotics for the treatment of Mycobacterium abscessus lung disease”
• September 27, 2022 – Dr. Yi Zhang, CDI Faculty Member seminar: “When inflammatory T cells meet tissue stem cells: how to control tissue damage or protection?”
• September 13, 2022 – Dr. Rodney Rothstein, Distinguished Speaker seminar: “Seeing is believing: break–induced mitotic recombination from 1936 – 2022”
• June 28 – Dr. Lisa Carter–Harris, seminar: “Beyond a Closed–Ended Question: Understanding the Decision to Screen or Not for Lung Cancer”
• June 16 – Dr. Marc Williams – seminar: “Deciphering genome instability and evolution in human tumors”
• June 9 – Dr. Jennifer Marks, Postdoc seminar: “MET Exon 14 Skipping Mutation in Non–Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History.” Dr. Juntae Kwon, Postdoc seminar: “USP13 overexpression drives lineage plasticity in lung cancer via stabilizing MYC protein”
• May 26 – Dr. Amir Arastehfar, Postdoc seminar: “The impact of antifungal drugs on intracellular pathogenic fungi Candida glabrata and the influence of drug resistance on macrophage interaction” Dr. Pradeep Ramalingam, Ph.D., Postdoc seminar: “Reactivation of DNA Damage Response restores blood stem cell fitness during aging”
• April 26 – Dr. Michele Cote – seminar: “Somatic Mutations in High Grade Endometrial Cancers: Challenges and New Targets”
• March 17 – Dr. Jianxin Sun – seminar: “Regulation of Vascular Permeability by Latexin”
• March 8 – Dr. Binfeng Lu – seminar: “Tissue alarmin cytokines as a novel cancer immunotherapy”
• February 9 – Dr. Jian Yu – seminar: “Intestinal Regeneration needs a ‘STING'”
• January 13 – Dr. Gerhard Grüber, seminar: “Novel targets and –molecules derived from mechanistic and structural understanding of the mycobacterial F–ATP synthases”

• December 8 – Dr. Tiago Alfredo Rodrigues Beites – seminar: “Sabotaging Mycobacterium tuberculosis nutritional adaptation to the host
• November 16 – Dr. Jickky Sarathy, Ph.D., Postdoc seminar: “Targeted protein degradation in mycobacteria”
• November 16 – Dr. Manpreet Bariana, Postdoc seminar: “Targeting NF–κB in multiple myeloma with a small molecule inhibitor”
• November 8 – Dr. Lin Zhang, seminar: “Immunogenic Cell Death in Colorectal Cancer Therapy and Prevention”
• November 4 – Dr. Jacqueline Achkar – seminar: “Antibody–mediated immunity against TB: What have we learned so far
• October 21 – Dr. Robert Bowman – seminar: “Uncovering the basis of oncogene–dependency and subclonal evolution in hematopoietic transformation”
• October 6 – Dr. Ralph Francescone & Dr. Débora Barbosa Vendramini Costa – seminar: “Synaptic proteins promote microenvironmental support of pancreatic tumorigenesis”/li>
• September 22 – Dr. Kevin Tong, seminar: “SMAD4 in Colon Cancer: From Molecular Mechanisms to Modeling Cancer Progression”
• September 1 – Dr. Jayati Basu, seminar: “ThPOKing immune cell development and function”
• August 18 – Dr. Alvin Makohon–Moore, seminar: “Evolutionary analyses of human cancers”
• August 11 – Dr. Jigarkumar Desai, seminar: “Complement C5a signaling in antifungal host defense”
• July 22 – Dr. Weiguo Cui, seminar: “T cell exhaustion in chronic viral infection and cancer”
• June 30 – Dr. Lok To (Chris) Sham, seminar: “Exploiting capsule synthesis pathway in Streptococcus pneumoniae to identify new antimicrobial compounds”
• June 1 – Dr. Patrizia Mondello, seminar: “Precision epigenetic–immunotherapy for B–cell lymphoma”
• May 20 – Dr. Ali Torkamani, seminar: “Genotype First”
• May 12 – CDI | Georgetown – Postdoctoral Seminar Series Dr. Randi Williams: “Multilevel Approaches to Address Cancer Disparities in the Clinical Context” Dr. Shaymaa Bahnassy: ”Subclonal Hypermutation as a Potential Mechanism of Drug Resistance in HER2+/ER+ Breast Cancer”
• April 27 – Dr. Uday Ganapathy, Postdoc seminar: “A Leucyl–tRNA Synthetase Inhibitor withBroad–Spectrum Anti–Mycobacterial Activity”
• April 27 – Dr. Kelly O’Neill, Postdoc seminar: “Elucidating Molecular Heterogeneity Within theGlioblastoma Multiforme Tumor Microenvironment Using Matrix Assisted LaserDesorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI)”
• April 20 – Dr. Majid Kazemian, seminar: “Dissecting Host–pathogen interactions in infectious diseases: from cancer to COVID–19”
• April 15 – Dr. Theresa Li–Yun Chang, seminar: “Not all type I IFNs are the same: IFN epsilon in immune response, viral infection and cancer.”
• April 8 – Dr. Robert Klein, seminar: “The role of inherited genetic variation in prostate cancer”
• March 30 – Dr. Francesca Gany, seminar, “Multilevel Translational Research to Facilitate Health Equity”
• March 24 – Dr. Francesmary Modugno, seminar: “Of Mice and Women: New Directions in Ovarian Cancer Translational Research”
• March 17 – Dr. Michaela Reagan, seminar: “Investigating the Role of Fatty Acid Binding Proteins in Multiple Myeloma”
• March 4 – Dr. Yi Zhang, seminar: “The Epigenetic Control of T Cell Stemness: A Guiding Role of EZH2”
• February 18 – Dr. Fotini Gounari, seminar: “Co–operative signaling in double positive thymocyte development and transformation”
• February 10 – Dr. Khashayarsha Khazaie, seminar: “Regulatory T–cells in colorectal cancer”
• February 4 – Dr. Mone Zaidi, seminar: “Genes, Diseases and New Medicines – Lessons from Team Science”
• January 27 – Dr. Jaewon Min, seminar: “Telomerase–independent telomere maintenance mechanisms in human cancers”
• January 13 – Dr. Lindsey James, seminar: “Promoting Illiteracy: Altering the H3 methylation landscape through inhibition of methyl–lysine readers”

2020

• December 10 – Dr. Michail Lionakis, seminar: “Of mice and humans: Host defense against fungal disease”
• November 24 – Dr. Meenal Datta, Seminar: “Abnormal Mechanics in Brain Tumors: Implications for Immunotherapy”
• November 19 – Dr. David van Duin, Seminar: “Infections in immunocompromised hosts: challenges and opportunities”
• November 11 – Dr. Nagi G. Ayad, Seminar: “Multi–omics approaches for identifying synergistic combinations in brain cancer”
• November 3 – Alexandre Cheng, Ph.D. student, seminar: “Liquid biopsies for infectious and immune diseases
• October 27 – Dr. Megan Mitchell, Postdoctoral seminar, “Optimization of a versatile, high–purity exosome purification assay for biomarker discovery” Dr. Dereje Negatu, Postdoctoral seminar, “Human gut microbiota metabolite targets amino acid biosynthesis in Mycobacterium tuberculosis”
• October 15 – Dr. Jason Sheltzer, seminar: “The role of aneuploidy in cancer development”
• October 7 – Dr. Warren J. Leonard, seminar – “The γc family of cytokines and fine–tuning their signals”
• September 22 – Dr. Francesca Ferraro, seminar: “Immune evasion mechanisms by de novo Acute Myeloid Leukemia Cells”/li>
• July 29 – Dr. Jonathan Yewdell – seminar: “Antibody Immunodominance to Viruses”
• July 22 – Dr. Minh Hong Thi Nguyen, seminar: “Opportunistic infections complicating viral infections”
• July 20 – Dr. Grant Challen, seminar: “The Epigenetic Regulation of Hematopoietic Stem Cells – From Clonal Hematopoiesis to Blood Cancers”
• July 17 – Dr. Wendy Chung, Genomic Medicine Series seminar: “Opportunities in Genomic Medicine”
• July 14 – Dr. Leandro Cerchietti, seminar: “Clinical and biological subtypes of B–cell lymphoma revealed by microenvironmental signatures”
• July 7 – Dr. Brendon Lee, seminar: “Predicting antibiotic resistance mutations in Mycobacterium tuberculosis using protein engineering”
• June 17 – Dr. Mark Bustoros, seminar: “Advancements in precursor states of Plasma cell Dycrasias”
• April 27 – Dr. Kelly O’Neill, Postdoc seminar: “Elucidating Molecular Heterogeneity Within the Glioblastoma Multiforme Tumor Microenvironment Using Matrix Assisted LaserDesorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI)”
• May 22 – Dr. Sharon Manne, seminar: “Cancer Survivorship: State of the Science, Models of Care, and Interventions to Improve Self–Management”
• May 13 – Dr. Katrin D. Mayer–Barber, seminar: “Granulocytic Immune responses to Mtb – Eosinophils kick it off!”
• March 9 – Dr. Mary Beth Terry, Genomic Medicine Series seminar: “Improving Cancer Risk Stratification and Risk Reduction”
• March 4 – Dr. Stephen Sykes, seminar: “Regulation of Serine Synthesis & Catabolism in Acute Myeloid Leukemia”
• March 3 – Dr. Jyothi Nagajyothi, seminar: “Adipose tissue, Adipocytes, and Adipomes– the regulators of TB pathology”
• February 5 – Dr. Scott Evans, seminar: “Developments in Oncology Clinical Trials”
• January 27 – Virginia Pascual, seminar: “New Insights into Pediatric Lupus Pathogenesis/li>
• January 24 – Dr. Masood Kamali–Moghaddam, seminar: “Molecular Tools for Parallel Detection and Characterization of Proteins and Exosome”
• January 13 – Chen Zhao, seminar: “NF– B/Notch Signaling in B cell transformation and Plasticity”